Peter M.K. Westcott
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 3
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Minh D. To (4 shared papers)Tyler Jacks (12 shared papers)Allan Balmain (3 shared papers)Reyno Delrosario (2 shared papers)Kay E. Gurley (1 shared paper)Erik Fredlund (1 shared paper)Alistair G. Rust (1 shared paper)Kyle Halliwill (1 shared paper)
- Journals
- Nature (3 papers)Science Translational Medicine (2 papers)Nature Communications (2 papers)Nature Cancer (2 papers)Chinese Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Peter M.K. Westcott
18 papers receiving 1.0k citations
Peter M.K. Westcott's Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 319
- Oncology 432
- Immunology 218
- Molecular Biology 631
- Pulmonary and Respiratory Medicine 166
Countries citing papers authored by Peter M.K. Westcott
This map shows the geographic impact of Peter M.K. Westcott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M.K. Westcott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M.K. Westcott more than expected).
Fields of papers citing papers by Peter M.K. Westcott
This network shows the impact of papers produced by Peter M.K. Westcott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M.K. Westcott. The network helps show where Peter M.K. Westcott may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter M.K. Westcott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 239 | |
| 2 | 2020 | 133 | |
| 3 | 2021 | 105 | |
| 4 | 2019 | 103 | |
| 5 | 2012 | 75 | |
| 6 | 2012 | 68 | |
| 7 | 2022 | 66 | |
| 8 | 2020 | 59 | |
| 9 | SOX17 enables immune evasion of early colorectal adenomas and cancers Hit paper breakdown → | 2024 | 47 |
| 10 | 2020 | 42 | |
| 11 | 2021 | 34 | |
| 12 | 2022 | 23 | |
| 13 | 2009 | 14 | |
| 14 | 2022 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2021 | 3 | |
| 17 | 2024 | 1 | |
| 18 | 2018 | 1 |
About Peter M.K. Westcott
Peter M.K. Westcott is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (3 papers), Immune Cell Function and Interaction (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Cancer Research (319 citations), Oncology (432 citations), Immunology (218 citations), Molecular Biology (631 citations) and Pulmonary and Respiratory Medicine (166 citations). Peter M.K. Westcott has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Minh D. To, Tyler Jacks, Allan Balmain, Reyno Delrosario, Kay E. Gurley, Erik Fredlund, Alistair G. Rust, Kyle Halliwill, Kuang‐Yu Jen and David J. Adams. Their work appears in journals such as Nature, Science Translational Medicine, Nature Communications, Nature Cancer and Chinese Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.